Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

NSE:NIDAN Revenue

In the fiscal year ending March 31, 2026, Nidan Laboratories and Healthcare had annual revenue of 255.42M INR with 4.13% growth. Nidan Laboratories and Healthcare had revenue of 124.21M in the half year ending March 31, 2026, with 0.55% growth.

• Revenue: 255.42M
• Revenue Growth: +4.13%
• P/S Ratio: 0.73
• Revenue / Employee: 1.57M
• Employees: 163
• Market Cap: 187.65M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	255.42M	10.14M	4.13%
Mar 31, 2025	245.28M	3.50M	1.45%
Mar 31, 2024	241.77M	-885.00K	-0.36%
Mar 31, 2023	242.66M	-53.94M	-18.19%
Mar 31, 2022	296.60M	88.68M	42.65%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 21, 2026

Data Sources Report a data error